These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 7340722)

  • 1. Rabies vaccine (Babeş strain of fixed rabies virus) inactivated with betapropiolactone.
    Toacsen E; Serban O; Moraru S
    Arch Roum Pathol Exp Microbiol; 1981; 40(4):333-9. PubMed ID: 7340722
    [No Abstract]   [Full Text] [Related]  

  • 2. Rabies vaccine prepared from the virus grown in Japanese quail embryo cell cultures.
    Bektemirova MS; Pille ER; Matevosyan KS; Nagieva FG
    Acta Virol; 1983 Jan; 27(1):59-64. PubMed ID: 6133431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production in Vero cells of an inactivated rabies vaccine from strain FRV/K for animal and human use.
    el-Karamany RM
    Acta Virol; 1987 Aug; 31(4):321-8. PubMed ID: 2892381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rabies vaccine in Czechoslovakia. II. Lyophilized rabies vaccine from brain tissue inactivated by UV irradiation].
    Slonim D; Stastný F; Brázdová R
    Cesk Epidemiol Mikrobiol Imunol; 1983 Jan; 32(1):17-26. PubMed ID: 6218902
    [No Abstract]   [Full Text] [Related]  

  • 5. Properties of rabies vaccine freed of neuroallergenic factor from brain tissue.
    Pille ER; Karakuyumchan MK; Nadaichik LV
    Acta Virol; 1981 Sep; 25(5):304-8. PubMed ID: 6118049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purified chick embryo cell (PCEC) rabies vaccine for human use. Laboratory data.
    Barth R; Gruschkau H; Jaeger O; Milcke L; Weinmann E
    Behring Inst Mitt; 1984 Nov; (76):142-54. PubMed ID: 6525146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabies vaccine: traditional and novel approaches.
    Kieny MP; Desmettre P; Soulebot JP; Lathe R
    Prog Vet Microbiol Immunol; 1987; 3():73-111. PubMed ID: 3078836
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular tests for assessing the immunogenicity of rabies vaccines.
    Kiss Z; Tuboly S
    Acta Vet Acad Sci Hung; 1981; 29(4):349-58. PubMed ID: 7053012
    [No Abstract]   [Full Text] [Related]  

  • 9. Rhesus diploid rabies vaccine (adsorbed): a new rabies vaccine using FRhL-2 cells.
    Burgoyne GH; Kajiya KD; Brown DW; Mitchell JR
    J Infect Dis; 1985 Jul; 152(1):204-10. PubMed ID: 4008986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of rabies virus by hydrogen peroxide.
    Abd-Elghaffar AA; Ali AE; Boseila AA; Amin MA
    Vaccine; 2016 Feb; 34(6):798-802. PubMed ID: 26731189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rabies antibodies in ferrets after a single rabies vaccination].
    Mainka C; Heber L; Schneider W
    Zentralbl Veterinarmed B; 1988 Jan; 35(1):24-8. PubMed ID: 3376624
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biological traits and immunologic value of the Babeş strain of fixed rabies virus].
    Toacsen E; Moraru S
    Arch Roum Pathol Exp Microbiol; 1988; 47(2):121-4. PubMed ID: 3250362
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction in the dosage schedule of BPL-inactivated neural tissue vaccine for rabies prophylaxis in man.
    Tripathi KK; Madhusudana SN; Sahu A
    Indian J Med Res; 1990 Sep; 91():334-9. PubMed ID: 2269504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modification of the incubation period of the fixed Babeş strain in relation to the nature of the host cells. The effects on viral titer and on the immunogenic value of rabies vaccines].
    Serban O; Toacsen E
    Arch Roum Pathol Exp Microbiol; 1983; 42(1):87-91. PubMed ID: 6336510
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rabies vaccine in Czechoslovakia. I. Hempt's vaccine and its modification].
    Slonim D; Stastný F; Brázdová AR
    Cesk Epidemiol Mikrobiol Imunol; 1982 Sep; 31(5):257-65. PubMed ID: 6215991
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays.
    Moore SM; Ricke TA; Davis RD; Briggs DJ
    Biologicals; 2005 Dec; 33(4):269-76. PubMed ID: 16168666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of BHK-rabies vaccine in human volunteers.
    Lalosević D; Stankov S; Lazarević-Ivanc L; Lalosević V; Knezević I
    Med Pregl; 1998; 51 Suppl 1():17-9. PubMed ID: 9769650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptation of a Chinese ferret badger strain of rabies virus to high-titered growth in BHK-21 cells for canine vaccine development.
    Liu Y; Zhang S; Zhang F; Hu R
    Arch Virol; 2012 Dec; 157(12):2397-403. PubMed ID: 22886183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Humoral immune response as a laboratory criterion for evaluation of the effectiveness of rabies vaccines].
    Seroka D; Wysokińska T
    Med Dosw Mikrobiol; 1982; 34(1-2):61-71. PubMed ID: 7144329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.